ArticleBMJ open2025
Serum folate and dietary folate intake in beta thalassaemia trait: a case-control study from Sri Lanka.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation and correction of charcoal-stripped serum matrix bias in stable-isotope-dilution LC-MS/MS quantification of endogenous serum folates.Analytical and bioanalytical chemistry · 2026Article
- A Rare Combination of Hereditary Folate Malabsorption (SLC46A1 Gene Variant) and Beta-Thalassemia Trait.EJIFCC · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIneffective erythropoiesis, although at a mild degree, could make individuals with beta thalassaemia trait (BTT) vulnerable to folate deficiency. This could be more pronounced in communities where dietary intake of folate is substantially lower. We aimed to assess serum folate levels and dietary folate consumption in individuals with BTT and compare them with healthy matched controls.
designA case-control study.
settingThis study was conducted between June 2021 and June 2022 at a regional thalassaemia centre in Sri Lanka.
participantsThe study includes 100 sets of samples, including a BTT and an age-matched, sex-matched and body mass index-matched healthy individual from the same household in each set, aged between 6 and 25 years. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcomes were serum folate levels and the daily dietary intake of folate in BTTs and controls. Serum folate levels were determined using a fully automated Cobas immunoassay analyser. The dietary folate intake was determined by recording 24-hour dietary recall recorded over 3 consecutive days, with the average intake calculated.
resultsThe results suggested that 34% of cases and 24% of controls had serum folate deficiency (<3 ng/mL), while 37% of cases and 49% of controls were at risk (3-5.9 ng/mL) for folate deficiency. Overall, the serum folate level was not significantly different between the cases (mean; 4.88 ng/mL) and the controls (mean; 4.76 ng/mL) (p=0.759). Dietary folate intake was lower than the recommended dietary allowances in both groups, but not significantly different between the groups.
conclusionsThere were high levels of folate deficiency in both controls and those with BTT, while those with BTT were no more likely to be folate deficient than the controls. Based on our findings, a policy of indiscriminate folic acid supplementation for all with BTT does not seem rational.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.